Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
about
Lanthanide probes for bioresponsive imagingOvercoming the concentration-dependence of responsive probes for magnetic resonance imagingCell-permeable MR contrast agents with increased intracellular retentionWater and protein dynamics in sedimented systems: a relaxometric investigation.Structural optimization of Zn(II)-activated magnetic resonance imaging probes.Metal Chelating Crosslinkers Form Nanogels with High Chelation Stability.MR imaging probes: design and applications.Mechanisms of ZnII-activated magnetic resonance imaging agentsBioresponsive, cell-penetrating, and multimeric MR contrast agents.Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.Analytical methods for characterizing magnetic resonance probes.A modular system for the synthesis of multiplexed magnetic resonance probes.A (Fluoroalkyl)Guanidine Modulates the Relaxivity of a Phosphonate-Containing T1-Shortening Contrast Agent.Reporter protein-targeted probes for magnetic resonance imaging.Aqueous Eu(II)-Containing Complex with Bright Yellow LuminescenceOptical imaging of targeted β-galactosidase in brain tumors to detect EGFR levelsInteraction of Biphenyl-Functionalized Eu(2+)-Containing Cryptate with Albumin: Implications to Contrast Agents in Magnetic Resonance ImagingAqueous Lanthanide Chemistry in Asymmetric Catalysis and Magnetic Resonance Imaging.Tumor-specific detection of an optically targeted antibody combined with a quencher-conjugated neutravidin "quencher-chaser": a dual "quench and chase" strategy to improve target to nontarget ratios for molecular imaging of cancer.Functionalized 129Xe contrast agents for magnetic resonance imaging.Molecular imaging of in vivo gene expression.Strategies for in vivo imaging of enzyme activity: an overview and recent advances.A comprehensive review on controls in molecular imaging: lessons from MMP-2 imaging.Bioresponsive probes for molecular imaging: concepts and in vivo applications.Recent advances in the development of synthetic chemical probes for glycosidase enzymes.A Gd3Al tetranuclear complex as a potential bimodal MRI/optical imaging agent.Global and local mobility of apocalmodulin monitored through fast-field cycling relaxometrySynthesis and evaluation of MR probes for targeted-reporter imaging.Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.Glycosylated lanthanide cyclen complexes as luminescent probes for monitoring glycosidase enzyme activity.
P2860
Q27000361-F140D628-A933-4D69-B309-76819EA8EAFEQ27013727-49D1B621-BACC-4B20-8D01-269D829F13C3Q28755262-A419B982-CAD9-45CE-8D47-F358259FC533Q30625649-CE2B6091-7104-4E51-9526-4EC1397A3485Q30650060-B0C26C5D-0BA4-4388-B22F-E8E4F1BF3EF8Q30751363-F403F1CA-642F-458E-998B-CA0F2FA4EB3AQ30868199-F1EADEE9-5660-4459-918A-10F5AEA91D00Q33377534-3E486CB4-7549-4148-BE38-DBB1A6533373Q33470566-D3268B9C-41AC-4C66-B40D-BEDDA64B6599Q34115859-1B92435C-9E62-4952-B88B-1A50AAF7E914Q34280357-443B712D-0786-401C-9556-92B2AF467CB7Q34913014-FD240815-C65B-46F7-B318-E2D722327F28Q35458246-325A1619-3581-46DA-9CFA-FCBEDD9CE8FDQ35468836-25A22AC1-3A70-4556-A374-B0EDCFB56137Q35528676-5198A27E-B402-4DB5-9922-73267A17E4ECQ35624259-F11CA798-6604-4307-AF04-91D455EBB36BQ36393668-07CE5FBB-3719-43C1-B14F-77963B3FDB77Q37143146-823AC66E-0B9B-4387-8C85-C8973E7C2DBDQ37460453-F0F3B78B-EECE-4C23-86D4-A59AC9437EE7Q37633017-83ADF23D-4134-4D1D-A8E6-A381098E2825Q37855913-F1119637-4741-4F5B-A385-086C1FA86E24Q37873318-F5DB9792-53CE-4D18-A0EA-17A6CAD359F5Q38202093-2AF71FF7-9FDB-4A38-84C3-E9516A745C53Q38420827-52850DF8-7724-4BD0-B13E-03B5911CD5AFQ38519593-4ED6D82D-1AF8-4DBA-BA4E-586EEBDD8AFFQ39323989-CFD666CB-9F98-4F08-A244-CFA771CD94C9Q42184093-4DCE00BB-378F-4BC8-ABA7-E8C707EDCEB0Q42367441-1203AC0D-B92B-402C-9270-597EDF137072Q47873356-1CEACB56-288B-4D01-9752-05E7CD9BCD65Q48311111-1B21DA74-C41B-4C39-BEDD-121A24FB3809
P2860
Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
@ast
Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
@en
type
label
Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
@ast
Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
@en
prefLabel
Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
@ast
Mechanistic investigation of beta-galactosidase-activated MR contrast agents.
@en
P2093
P50
P356
P1433
P1476
Mechanistic investigation of beta-galactosidase-activated MR contrast agents
@en
P2093
Frank J Femia
Jeffrey Smith
Joseph A Duimstra
Lauren M Urbanczyk-Pearson
Thomas J Meade
P356
10.1021/IC700888W
P407
P577
2007-12-12T00:00:00Z